¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Gaviscon Extra Strength Liquid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • liquid suspension
    ¾×üºÎÀ¯¾×
  • liquid-filled stomach method
    À§Ã游°Ë»ç¹ý
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕ°­µµ
  • dynamic strength
    1. µ¿Àû±Ù·Â 2. µ¿Àû°­µµ
  • ego strength
    ÀÚ¾ÆÈû
  • ionic strength
    À̿°­µµ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • physical strength
    ü·Â
  • strength
    1. ¼¼±â, °­µµ 2. Èû
  • strength duration curve
    °­µµ±â°£°î¼±
  • shearing strength
    Àü´Ü°­µµ, ¾ù°¥¸²¼¼±â
  • tearing strength
    Âõ±è°­µµ, Àο­°­µµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • liquid-filled stomach method
    À§Ã游°Ë»ç¹ý
  • back strength
    µîÈû
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕÈû
  • strength duration curve
    °­µµ±â°£°î¼±
  • dynamic strength
    µ¿Àû±Ù·Â
  • ego strength
    ÀÚ¾ÆÈû
  • field strength
    ÀÚÀå¼¼±â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â, °¡ÀåÀÚ¸®ÀÚÀå¼¼±â
  • grasp strength
    Áã´ÂÈû
  • ionic strength
    À̿°­µµ
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • marginal strength
    °æ°è°­µµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • low-ionic--strength salt solution =LISS
    ÀúÀ̿°­µµ¿°¿ë¾×
  • low-ionic-strength salt solution TEST = LISS test
    ÀúÀ̿°­µµ¿°¿ë¾×
  • magnetic field strength
    ÀÚÀå ¼¼±â, Àڱ⠰­µµ
  • marginal strength
    ¿¬º¯°­µµ(æÞܫ˭öô).
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • muscle force =m. strength
    ±Ù ·Â(ÐÉæ³).
  • peak gradient strength
    ÃÖ°í °æ»ç ¼¼±â
  • physical strength
    ü·Â(ô÷æ³).
  • shearing strength
    Àü´Ü°­µµ(¡­Ë­öô).
  • strength
    °­µµ(Ë­öô), Èû, ¼¼±â.
  • strength duration curve
    °­µµ-±â°£°î¼±(Ë­ öôÑ¢ÊàÍØàÊ).
  • strength test
    °­µµ°Ë»ç
  • tearing strength
    Àο­µµ(ìÚæñöô).
  • tensile strength
    ½ÅÀå°­µµ(ãßíåË­öô).
  • tensile strength
    ½ÅÀå°­µµ(ãßíåË­öô)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • liquid crystal
    ¾×Á¤(äûïÜ)
  • liquid hybridization
    ¾×ü(äûô÷) Æ¢±â»ý¼º(ßæà÷)
  • liquid junction potential
    ¾×üÁ¢Á¡ÀüÀ§(äûô÷ïÈïÇï³êÈ)
  • liquid medium
    ¾×ü¹èÁö(äûô÷ÛÆò¢)
  • liquid protein diet
    ¾×ü´Ü¹éÁú½Ä(äûô÷Ó±ÛÜòõãÝ)
  • liquid scintillation
    ¾×ü¼¶±¤(äûô÷àìÎÃ)
  • liquid scintillation counter
    ¾×ü¼¶±¤°è¼ö±â(äûô÷àìÎÃͪâ¦Ðï)
  • liquid-solid chromatography
    ¾×ü-°íü(äûô÷ͳô÷) Å©·Î¸¶Åä±×·¡ÇÇ
  • liquid surfactant
    ¾×ü°è¸éȰ¼ºÁ¦(äûô÷Í£ØüüÀàõð­)
  • lyotropic liquid crystal
    À̾׾×Á¤(ìÆäûäûïÜ)
  • thermotropic liquid crystal
    Çâ¿­¼º¾×Á¤ (ú¾æðàõäûïÜ)
  • vapor-liquid partition chromatography
    Áõ±â-¾×ü (ñúѨäûô÷) ºÐ¹è(ÝÂÛÕ) Å©·Î¸¶Åä±×·¡ÇÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LLC Lewis lung carcinoma; liquid-liquid chromatography; long-leg cast; lymphocytic leukemia
LSC late systolic click; left side colon cancer; left subclavian; lichen simplex chronicus; liquid scint...
EC Extra-Cranial
ECCE Extra-Capsular Cataract Extraction
ECF   1) Eosinophilic Chemotatic Factors
  2) Extra-Cellular Fluid; ¼¼Æ÷ ¿Ü¾×
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LISS Low ionic strength solutions
RMS Respiratory muscle strength
SBS Shear bond strength
ST Strength training
TBS Tensile Bond Strength
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • powder-liquid method
    ºÐ, ¾×¹ý
  • wash liquid
    ¼¼¾×
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
  • fracture strength
    ÆÄÀý °­µµ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • margin strength
    º¯¿¬ °­µµ
    °­µµ¶õ ¾î¶² ¹°Ã¼¸¦ ÆÄ°ú½Ã۴µ¥ ÇÊ¿äÇÑ ÃÖ´ëÀÇ ÀÀ·ÂÀ¸·Î¼­ Àη¹ÀÌ ÁöÀ۽à marginal ridge ºÎÀ§¿¡ »ç¿ëµÇ´Â Àç·áÀÇ °­µµ¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î º¯¿¬°­µµ°¡ Å« Àç·áÀÎ °æ¿ì¿¡´Â cavo-surface angleÀº µÐ°¢ÀÌ µÇ°í ±× ¹Ý´ëÀÎ °æ¿ì¿¡´Â Á÷°¢¿¡ °¡±õ°Ô Çü¼ºÇØÁØ´Ù.
  • marginal strength
    º¯¿¬ °­µµ, ¿¬´Ü °­µµ
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • physical strength
    ü·Â
  • shear strength
    Àü´Ü °­µµ
    µÚƲ¸®´Â Èû ¶Ç´Â Á¢¼±À» µû¶ó ¿òÁ÷ÀÌ´Â Èû¿¡ ÀúÇ×ÇÏ´Â ¼ºÁú.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
strength-duration curve A graph relating the intensity of an electrical stimulus to the length of time it must flow to be effective.
See: chronaxie, rheobase.
(05 Mar 2000)
ionic strength Symbolised as g/2 or I and set equal to 0.5σmizi2, where mi equals the molar concentration and zi the charge of each ion present in solution; if molar concentrations (ci) are used instead of molality (and the solution is dilute), then I == 0.5(1/ρo)σcizi2 where ρo is the density of the solvent; a number of biochemically important events (e.g., protein solubility and rates of enzyme action) vary with the ionic strength of a solution.
(05 Mar 2000)
tensile strength The maximum stress a material subjected to a stretching load can withstand without tearing.
(12 Dec 1998)
yield strength The amount of stress at which a permanent (plastic) deformation in a component becomes measurable (usually taken as 0.2% permanent strain).
(05 Mar 2000)
ultimate strength The maximum stress achieved prior to failure of a component on a single application of the load.
(05 Mar 2000)
fatigue strength The stress level below which a particular component will survive an indefinite number of load cycles (typically about 50% of the ultimate strength of the component).
(05 Mar 2000)
gas-liquid chromatography <technique> A chemistry lab technique, a type of column chromatography, used to separate the components of a mixed substance.
The substance is held stationary by an inert solid coated with an inert liquid which is not likely to evaporate (i.e. Is nonvolatile), while a gas (called an eluant) flows past it bringing out the components one at a time.
(09 Oct 1997)
chromatography, high pressure liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.
(12 Dec 1998)
chromatography, liquid Chromatographic techniques in which the mobile phase is a liquid.
(12 Dec 1998)
clear liquid diet A diet, often used postoperatively, consisting usually of water, tea, coffee, gelatin preparations, and clear soups or broth.
(05 Mar 2000)
Cotunnius' liquid <anatomy> The fluid which surrounds the membranous labyrinth of the internal ear, and separates it from the walls of the chambers in which the labyrinth lies.
Source: Websters Dictionary
(01 Mar 1998)
heavy liquid petrolatum <chemical> A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.
Pharmacological action: cathartic, emollients, ointment bases.
Chemical name: Hydrocarbon oils
(12 Dec 1998)
high-performance liquid chromatography <investigation> A lab technique, a type of column chromatography, which uses a combination of several separation techniques to separate substances at higher resolution. Extremely sharp peaks on the elution profile can be produced with high-performance liquid chromatography (HPLC).
(09 Oct 1997)
high-pressure liquid chromatography <investigation> A lab technique, a type of column chromatography, which uses a combination of several separation techniques to separate substances at higher resolution. Extremely sharp peaks on the elution profile can be produced with high-performance liquid chromatography (HPLC).
(09 Oct 1997)
immersion liquid <microscopy> Any liquid occupying the space between the object and microscope objective. Such a liquid is usually required by objectives of 3-mm focal length or less. For best results (i.e., resolution) the liquid should be used between the condenser and the microscope slide. Immersion objectives for transmitted light are designed for use with either oil, glycerin, or water, the refractive index of the liquid and the coverslip (if any) being the determining factor. The liquid and the front lens of the objective should ideally coincide in index and in dispersion value.
See: homogeneous immersion objective
(05 Aug 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Dutch liquid
    ¿°È­ ¿¡Æ¿·»
  • gas liquid chromatography
    =GAS CHROMATOGRATOGRAPHY
  • liquid
    ¾×ü(À¯µ¿Ã¼)ÀÇ;(ÀÛÀº »õ ¼Ò¸®,ÇÏ´Ã ºû µîÀÌ) ¸¼Àº;À¯Ã¢ÇÑ;À¯À½ÀÇ;(°øÃ¤ µî) µ·À¸·Î ¹Ù²Ü ¼ö ÀÖ´Â
  • liquid
    ¾×ü;À¯µ¿Ã¼;À¯À½
  • liquid air
    ¾×ü°ø±â
  • liquid fire
    ¾×È­(È­¿°¹æ»ç±â¿¡¼­ ¹ß»çµÇ´Â)
  • liquid fuel
    (·ÎÄÏÀÇ)¾×ü¿¬·Î
  • liquid measure
    ¾×·®
  • liquid sound
    À¯À½
  • semi liquid
    na;¹Ý ¾×ü(ÀÇ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á